Oncology And Women's Health Will Flourish With AI
AN
AnalystConsensusTarget
Not Invested
Consensus Narrative from 20 Analysts
Published
11 May 25
Updated
15 Aug 25
AnalystConsensusTarget's Fair Value
US$198.58
16.6% undervalued intrinsic discount15 Aug
US$165.60
1Y
35.0%7D
1.6%